Pain 2021 Sep 2. Epub 2021 Sep 2.
TOTALL Diabetes Hormone Institute, Indore, India; Kovai Diabetes Speciality Centre and Hospital; Coimbatore, India; Glenmark Pharmaceuticals Limited, Mumbai, India; Ichnos Sciences, Inc., New York, NY; Early Clinical Development Consulting Ltd., Macclesfield, United Kingdom; Department of Neurology, Harvard Medical School, Boston, MA; Division of Neurological Pain Research and Therapy, Universitätsklinikum Schleswig-Holstein, Campus-Kiel, Germany Janssen Pharmaceuticals, Inc., Cambridge, MA.
Abstract: Patients with chronic pain syndromes, such as those with painful peripheral neuropathy due to diabetes mellitus, have limited treatment options and suffer ongoing attrition of their quality of life. Safer and more effective treatment options are needed. One therapeutic approach encompasses phenotypic characterization of the neuropathic pain subtype, combined with the selection of agents that act on relevant mechanisms. Read More